Psychemedics Corp. (PMD)
NASDAQ:PMD
US Market

Psychemedics (PMD) Stock Price & Analysis

99 Followers

PMD Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$4.85 - $7.25
Previous Close$5.51
Volume2.71K
Average Volume (3M)6.26K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$3.46M
Total Debt (Recent Filing)$3.92M
Price to Earnings (P/E)-15.3
Beta0.21
Next EarningsMar 07, 2023
EPS EstimateN/A
Dividend Yield0.26 (3.74%)
1Y Price TargetN/A
EPS (TTM)-0.36
Shares Outstanding5,644,696
R-Squared0.08
Standard Deviation0.11
10 Day Avg. Volume3,307
30 Day Avg. Volume6,262
Price to Book (P/B)2.70
Price to Sales (P/S)1.62
Price to Cash Flow (P/CF)8.80
P/FCF Ratio15.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target UpsideN/A
Rating ConsensusN/A
Alpha-0.02
Number of Analyst Covering0


Financials

Annual

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

PMD FAQ

What was Psychemedics’s price range in the past 12 months?
Psychemedics lowest stock price was $4.85 and its highest was $7.25 in the past 12 months.
    What is Psychemedics’s market cap?
    Currently, no data Available
    When is Psychemedics’s upcoming earnings report date?
    Psychemedics’s upcoming earnings report date is Mar 07, 2023 which is in 31 days.
      How were Psychemedics’s earnings last quarter?
      Psychemedics released its earnings results on Nov 09, 2022. The company reported -$0.017 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.017.
        Is Psychemedics overvalued?
        According to Wall Street analysts Psychemedics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Psychemedics pay dividends?
          Psychemedics pays a Annually dividend of $0.07 which represents an annual dividend yield of 3.74%. See more information on Psychemedics dividends here
            What is Psychemedics’s EPS estimate?
            Psychemedics’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Psychemedics have?
            Psychemedics has 5,644,696 shares outstanding.
              What happened to Psychemedics’s price movement after its last earnings report?
              Psychemedics reported an EPS of -$0.017 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.644%.
                Which hedge fund is a major shareholder of Psychemedics?
                Among the largest hedge funds holding Psychemedics’s share is Royce & Associates LLC. It holds Psychemedics’s shares valued at N/A.

                  ---

                  Psychemedics Stock Smart Score

                  2
                  Underperform
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Negative
                  20 days / 200 days
                  Momentum
                  -19.37%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  -15.67%
                  Trailing 12-Months
                  Asset Growth
                  -13.35%
                  Trailing 12-Months
                  The Psychemedics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Psychemedics Corp.

                  Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. It specializes in a five panel drug testing process for cocaine, opioids, Phenyclidine, amphetamines, and marijuana. It offers workplace, school, and personal drug testing services. The company was founded by Werner Baumgartner and Annette Baumgartner on September 24, 1986 and is headquartered in Acton, MA.

                  ---

                  Forecast EPS vs Actual EPS


                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  ATI Physical Therapy
                  Bitech Technologies Corporation
                  Medical Marijuana
                  Cryo-Cell International

                  Popular Stocks

                  ---
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis